Rankings
▼
Calendar
DSGN FY 2021 Earnings — Design Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
DSGN
Design Therapeutics, Inc.
$569M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$36M
Net Income
-$36M
EPS (Diluted)
$-0.77
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$31M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$391M
Total Liabilities
$8M
Stockholders' Equity
$382M
Cash & Equivalents
$299M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$5,000
+100.0%
Operating Income
-$36M
-$9M
-318.8%
Net Income
-$36M
-$8M
-329.1%
← Q4 2020
All Quarters
Q1 2021 →